Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
Background While vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides significant protection from coronavirus disease 2019, the protection afforded to individuals with chronic lung disease is less well established. This study seeks to understand how chronic lung...
Main Authors: | Haolin Liu, Katja Aviszus, Pearlanne Zelarney, Shu-Yi Liao, Anthony N. Gerber, Barry Make, Michael E. Wechsler, Philippa Marrack, R. Lee Reinhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2023-10-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/9/5/00400-2023.full |
Similar Items
-
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
by: Haolin Liu, et al.
Published: (2021-01-01) -
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity
by: Haolin Liu, et al.
Published: (2022-09-01) -
Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021-03-01) -
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
by: Ruofan Li, et al.
Published: (2022-08-01) -
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
by: María C. García‐Hidalgo, et al.
Published: (2022-05-01)